Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05739955 · ClinicalTrials.gov registry record · NA
Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms
A NA study of Disinfection, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 918
- Enrollment target
- 1
- Study location
NCT05739955: Recruiting NA study of Disinfection, sponsored by Duke University.
NCT05739955 is a NA study of Disinfection that is actively recruiting participants, run by Duke University. The registered enrollment target is 918 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05739955, a NA study of Disinfection, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 918 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if enhanced daily application of disinfectant with persistent 24-hour activity decreases the environmental bioburden compared to standard practice.
Primary Outcome
Total contamination, in colony-forming units (CFUs) on environmental surfaces on study days 1 and 2
Conditions Studied
Interventions
- OTHER Sani24
- OTHER Standard EPA-registered disinfectant
- OTHER Routine Disinfection
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 918 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2026-02 |
| Phase | NA |
What NCT05739955 shows while recruiting
NCT05739955 is an interventional study that assigns participants to a tested intervention. The registered 918 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Disinfection appearing as the primary indexed condition, and to 3 interventions - of which Sani24 is the first listed.
NCT05739955 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05739955 about?
NCT05739955 is a clinical study titled "Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms". The purpose of this study is to determine if enhanced daily application of disinfectant with persistent 24-hour activity decreases the environmental bioburden compared to standard practice.
What is the current status of trial NCT05739955?
This trial is currently recruiting. It is a NA study. The enrollment target is 918 participants. The study started on 2023-02-13. Estimated completion is 2026-02.
What conditions does trial NCT05739955 study?
This clinical trial studies the following conditions: Disinfection.
What interventions are being tested in trial NCT05739955?
The interventions under investigation include: Sani24 (OTHER), Standard EPA-registered disinfectant (OTHER), Routine Disinfection (OTHER).
Who is sponsoring clinical trial NCT05739955?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05739955 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05739955's enrollment target sits among peer trials
918 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- NCT07174336 · 920 participants · Phase 3
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI